{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:09:45Z","timestamp":1788923385158,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.leukres.2021.106614","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T11:40:02Z","timestamp":1620646802000},"page":"106614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5959","authenticated-orcid":false,"given":"Hong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan M.","family":"Kadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-7107","authenticated-orcid":false,"given":"Siba","family":"El Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.leukres.2021.106614_bib0005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2016-08-692566","article-title":"Peripheral T-cell lymphoma, not otherwise specified","volume":"129","author":"Broccoli","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2021.106614_bib0010","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2021.106614_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2021.106614_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106614_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-319-99716-2_6","article-title":"Anaplastic large cell lymphoma: contemporary concepts and optimal management","volume":"176","author":"Shustov","year":"2019","journal-title":"Cancer Treat. Res."},{"issue":"5","key":"10.1016\/j.leukres.2021.106614_bib0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ejh.13038","article-title":"Chronic lymphoproliferative disorder of NK-cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools","volume":"100","author":"Kurt","year":"2018","journal-title":"Eur. J. Haematol."},{"issue":"10","key":"10.1016\/j.leukres.2021.106614_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102900","article-title":"Aggressive NK cell leukemia: current state of the art","volume":"12","author":"El Hussein","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.leukres.2021.106614_bib0040","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000001518","article-title":"Genomic and immunophenotypic landscape of aggressive NK-cell leukemia","volume":"44","author":"El Hussein","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106614_bib0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106614_bib0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1200\/EDBK_200689","article-title":"Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia","volume":"38","author":"Moignet","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.leukres.2021.106614_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106299","article-title":"Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: a single-institution experience","volume":"90","author":"Zhu","year":"2020","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2021.106614_bib0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.leukres.2021.106614_bib0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2015.00230","article-title":"Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies","volume":"6","author":"Pittari","year":"2015","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106614_bib0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/eji.1830270230","article-title":"The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules","volume":"27","author":"Carretero","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2021.106614_bib0075","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.158.8.3603","article-title":"Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C","volume":"158","author":"Houchins","year":"1997","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106614_bib0080","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/0008-5472.CAN-14-1643","article-title":"ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors","volume":"75","author":"Cifaldi","year":"2015","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.leukres.2021.106614_bib0085","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI123955","article-title":"Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells","volume":"129","author":"Kamiya","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.leukres.2021.106614_bib0090","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/2326-6066.CIR-18-0885","article-title":"Enriched HLA-E and CD94\/NKG2A interaction limits antitumor CD8(+) tumor-infiltrating t lymphocyte responses","volume":"7","author":"Abd Hamid","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"Pt 2","key":"10.1016\/j.leukres.2021.106614_bib0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2017.10.001","article-title":"Emerging targets in cancer immunotherapy","volume":"52","author":"Burugu","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106614_bib0100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106614_bib0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jcp.54.3.224","article-title":"Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype","volume":"54","author":"Dukers","year":"2001","journal-title":"J. Clin. Pathol."},{"issue":"11","key":"10.1016\/j.leukres.2021.106614_bib0110","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2021.106614_bib0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2141.2000.02159.x","article-title":"Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type","volume":"110","author":"Hoffmann","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106614_bib0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.leu.2404168","article-title":"NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis","volume":"20","author":"Morice","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2021.106614_bib0125","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2141.2003.04201.x","article-title":"Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia","volume":"120","author":"Morice","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106614_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41379-019-0322-9","article-title":"The inhibitory receptor CD94\/NKG2A on CD8(+) tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE\/beta2m overexpression","volume":"33","author":"Eugene","year":"2020","journal-title":"Mod. Pathol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:56Z","timestamp":1758934856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":26,"alternative-id":["S0145212621001156"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106614","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106614"}}